‘TIME’ featured in latest issue of Genetic Engineering & Biotechnology News

Posted on Posted in News

Cambridge UK, 9th August 2017 – Bactevo’s Totally Integrated Medicines Engine (TIME) technology has been featured in the latest issue of Genetic Engineering & Biotechnology News (GEN). Click here to read the article. About Bactevo Bactevo has built a unique and game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Utilising its paradigm shift in the speed, efficiency […]

Bactevo unveils ‘TIME’ a novel, game-changing medicines discovery platform

Posted on Posted in News

Achieves 100 Million Disease-Relevant Assays per Hour Incorporates Ground-Breaking Synthetic Chemistry Platform Management Team and SAB Expanded to Accelerate Next Phase of Growth 25th April, 2017 CAMBRIDGE, UK – Bactevo Ltd today unveiled a game-changing Totally Integrated Medicines Engine (TIME) capable of 100 million phenotypic assays per hour, a landmark in disease-relevant assay screening. TIME […]

Bactevo Wins Innovate Award

Posted on Posted in News

Cambridge UK, 25th January 2017 – Bactevo, the revolutionary Cambridge, UK-based drug discovery company has received an Innovate Award for a prestigious £1.5M grant. Exploiting revolutionary work in the field of integrated, accelerated drug discovery in micro-droplets, Bactevo will progress its programmes focused on generating new antibiotic drugs to highly drug resistant Gram-negative pathogens causing septicaemia, chest […]

Drug Discovery Revolution- The Beginning?

Posted on Posted in News

Bactevo are delighted to announce the date of September 28th, 2017 for the second ChemBioSphere meeting (entitled ChemBioSphere: Reprogramming Drug Discovery), following the enormous success of the inaugural meeting last week. Four one-day meetings will be held in successive years aimed at bringing together experts, change makers and decision leaders from every part of the […]

Bactevo Raises Financing for Synthetic Biology

Posted on Posted in News

Cambridge UK, December 10th 2014 – Bactevo, the Industrial Biotechnology company, announced today that it has raised additional financing from New Wave Ventures LLP. The financing puts the company in an excellent position for ongoing and future commercial discussions. Bactevo is a Cambridge UK-based company utilising its proprietary molecular engineering technologies, known as TarGET, to […]

Bactevo Spins Off from Discuva

Posted on Posted in News

Cambridge UK, 12th December 2012- Bactevo has spun-off from the antibiotics discovery company Discuva to develop its core technology expertise in the Industrial Biotechnology sector. Bactevo is a Cambridge UK-based company utilising its proprietary molecular engineering technologies, known as TarGET, to enable the use of bacteria for the synthesis of chemicals from sustainable resources. With […]